-
公开(公告)号:US12188015B2
公开(公告)日:2025-01-07
申请号:US17254169
申请日:2019-06-21
Inventor: Ailong Ke , Adam Dolan , Yan Zhang , Zhonggang Hou
Abstract: Provided are compositions, methods, and kits for CRISPR-based editing of DNA targets by Type I CRISPR-associated (Cas) enzymes.
-
公开(公告)号:US20240229081A1
公开(公告)日:2024-07-11
申请号:US18563175
申请日:2022-05-26
Inventor: Yan Zhang , Zhonggang Hou , Renke Tan , Ailong Ke
CPC classification number: C12N15/907 , C12N9/22 , C12N15/11 , C12N2310/20 , C12N2800/80
Abstract: The present disclosure provides systems and methods of altering a nucleic acid sequence, which comprise an engineered Type I CRISPR/Cas system comprising Cas3 and Cas11. Particularly. the system and methods described herein use compact engineered CRISPR-Cas3 systems (e.g., Type I-C, Type I-B, or Type I-D) for genetic manipulations (e.g., in eukaryotic cells).
-
公开(公告)号:US20230287457A1
公开(公告)日:2023-09-14
申请号:US18000676
申请日:2021-05-26
Inventor: Yan Zhang , Ailong Ke , Ryan Krueger , Zhonggang Hou
CPC classification number: C12N15/907 , C12N15/11 , C12N9/22 , C12N15/70 , C12N2310/20 , C12N2800/80
Abstract: The disclosure provides a method of altering a DNA sequence, which method comprises the use of a type I-C CRISPR-Cas system based on Neisseria lactamica. The system involves a combination of two or more Neisseria lactamica proteins selected from Cas3, Cas5, Cas8c, and Cas7 and a synthetic guide RNA sequence.
-
-